Skip Navigation
  Print Page

Staff Detail

Skip sharing on social media links
Share this:

Moye, Jack

Formal Title:

Medical Officer

Responsibilities:

Director of Repository and Laboratories and Acting Director National Children's Study

Phone:

301-594-8624

Email:

moyej@mail.nih.gov

Address:

6100 EXECUTIVE BLVD Room 3G01, MSC 7510
Bethesda Md 20892-7510
For FedEx use:
Rockville Md 20852

Biosketch:

Jack Moye, Jr., MD is a pediatrician and former state public health laboratory official who joined the National Children's Study Program Office to serve as Senior Scientist and Director of Repository and Laboratories.  He came to the National Children's Study from within the Eunice Kennedy Shriver National Institute of Child Health and Human Development, where from 1991–2007 he was a member of the Pediatric, Adolescent, and Maternal AIDS Branch in the Center for Research for Mothers and Children. There his areas of responsibility included laboratory quality assurance, biospecimen repository management, virology and immunology research, epidemiologic cohort studies and clinical trials, growth and nutrition, and international research initiatives. His background is in clinical and laboratory medicine and in preventive medicine and public health, with emphasis on prevention and control of communicable and chronic diseases, including sexually transmitted diseases and HIV/AIDS. He is a member of the research team that conducted AIDS Clinical Trials Group protocol 076 (ZDV to prevent mother-to-child HIV transmission) and has been a member of panels and task forces for the U.S. Public Health Service Surgeon General, the U.S. Conference of Mayors, the New England Governors Conference, and the Massachusetts Governor, and a consultant to state and city departments of health, social services, corrections, youth services, and education.

Publications (PubMed):

 
Title Authors Publication Date
Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy.Chantry CJ,Cervia JS,Hughes MD,Alvero C,Hodge J,Borum P,Moye J Jr,PACTG 1010 TeamHIV Med2010 Oct 1
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children.HIV Paediatric Prognostic Markers Collaborative Study,Boyd K,Dunn DT,Castro H,Gibb DM,Duong T,Aboulker JP,Bulterys M,Cortina-Borja M,Gabiano C,Galli L,Giaquinto C,Harris DR,HugheS M,McKinney R,Mofenson L,Moye J,Newell ML,Pahwa S,Palumbo P,Rudin C,Sharland M,Shearer W,Thompson B,Tookey PAIDS2010 May 15
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.Connor EM,Sperling RS,Gelber R,Kiselev P,Scott G,O'Sullivan MJ,VanDyke R,Bey M,Shearer W,Jacobson RLN Engl J Med1994 Nov 3
Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection.Mitchell CD,Chernoff MC,Seage GR 3rd,Purswani MU,Spiegel HM,Zilleruelo G,Abitbol C,Heckman B,Ponce CB,Oleske JM,IMPAACT 219/219C Study TeamPediatr Nephrol2015 Jan
Early viral suppression improves neurocognitive outcomes in HIV-infected children.Crowell CS,Huo Y,Tassiopoulos K,Malee KM,Yogev R,Hazra R,Rutstein RM,Nichols SL,Smith RA,Williams PL,Oleske J,Muller WJ,PACTG 219C Study Team and the Pediatric HIVAIDS Cohort Study (PHACS)AIDS2015 Jan 28
Medication adherence in children and adolescents with HIV infection: associations with behavioral impairment.Malee K,Williams P,Montepiedra G,McCabe M,Nichols S,Sirois PA,Storm D,Farley J,Kammerer B,PACTG 219C TeamAIDS Patient Care STDS2011 Mar
Tetanus immunity after diphtheria, tetanus toxoids, and acellular pertussis vaccination in children with clinically stable HIV infection.Rosenblatt HM,Song LY,Nachman SA,Stanley KE,Krogstad PA,Johnson GM,Wiznia AA,Pediatric Aids Clinical Trials Group 377 Study TeamJ Allergy Clin Immunol2005 Sep
Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection.Rosenblatt HM,Stanley KE,Song LY,Johnson GM,Wiznia AA,Nachman SA,Krogstad PA,Pediatric AIDS Clinical Trials Group 377 Study TeamJ Infect Dis2005 Aug 1
The utility of IgA antibody to human immunodeficiency virus type 1 in early diagnosis of vertically transmitted infection. National Institute of Allergy and Infectious Diseases and National Institute of Child Health and Human Development Women and Infants Transmission Study Group.McIntosh K,Comeau AM,Wara D,Diaz C,Landesman S,Pitt J,Rich K,Lew J,Moye J,Kalish LAArch Pediatr Adolesc Med1996 Jun
Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. NAID/NICHD Women and Infants Transmission Study Group.Landay AL,Brambilla D,Pitt J,Hillyer G,Golenbock D,Moye J,Landesman S,Kagan JClin Diagn Lab Immunol1995 Jul
Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia.Borkowsky W,Yogev R,Muresan P,McFarland E,Frenkel L,Fenton T,Capparelli E,Moye J,Harding P,Ellis N,Heckman B,Kraimer JVaccine2008 Jun 6
Nevirapine concentrations in newborns receiving an extended prophylactic regimen.Mirochnick M,Nielsen-Saines K,Pilotto JH,Pinto J,Jiménez E,Veloso VG,Parsons T,Watts DH,Moye J,Mofenson LM,Camarca M,Bryson Y,NICHD/HPTN 040/PACTG 1043 Protocol TeamJ Acquir Immune Defic Syndr2008 Mar 1
Planned multiple exposures to autologous virus in HIV type 1-infected pediatric populations increases HIV-specific immunity and reduces HIV viremia.Borkowsky W,Yogev R,Muresan P,McFarland E,Frenkel L,Fenton T,Capparelli E,Moye J,Harding P,Ellis N,Heckman B,Kraimer JAIDS Res Hum Retroviruses2008 Mar
Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children.Chantry CJ,Frederick MM,Meyer WA 3rd,Handelsman E,Rich K,Paul ME,Diaz C,Cooper ER,Foca M,Adeniyi-Jones SK,Moye JPediatr Infect Dis J2007 Jan
Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV.Foca M,Moye J,Chu C,Matthews Y,Rich K,Handelsman E,Luzuriaga K,Paul M,Diaz C,Women and Infants Transmission StudyPediatrics2006 Jul
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.Kovacs A,Cowles MK,Britto P,Capparelli E,Fowler MG,Moye J,McIntosh K,Rathore MH,Pitt J,Husson RNPediatr Infect Dis J2005 Jun
Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.Lambert JS,Moye J Jr,Plaeger SF,Stiehm ER,Bethel J,Mofenson LM,Mathieson B,Kagan J,Rosenblatt H,Paxton H,Suter H,Landay AClin Diagn Lab Immunol2005 May
Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.Nachman SA,Lindsey JC,Moye J,Stanley KE,Johnson GM,Krogstad PA,Wiznia AA,Pediatric AIDS Clinical Trials Group 377 Study TeamPediatr Infect Dis J2005 Apr
Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis.Ioannidis JP,Tatsioni A,Abrams EJ,Bulterys M,Coombs RW,Goedert JJ,Korber BT,Mayaux MJ,Mofenson LM,Moye J Jr,Newell ML,Shapiro DE,Teglas JP,Thompson B,Wiener JAIDS2004 Jan 2
Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.Nachman S,Kim S,King J,Abrams EJ,Margolis D,Petru A,Shearer W,Smith E,Moye J,Blanchard S,Hawkins E,Bouquin P,Vink P,Benson M,Estep S,Malinoski F,Pediatric AIDS Clinical Trials Group Study 292 TeamPediatrics2003 Jul
Bioelectrical impedance analysis models for prediction of total body water and fat-free mass in healthy and HIV-infected children and adolescents.Horlick M,Arpadi SM,Bethel J,Wang J,Moye J Jr,Cuff P,Pierson RN Jr,Kotler DAm J Clin Nutr2002 Nov
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions.Bunupuradah T,Duong T,Compagnucci A,McMaster P,Bernardi S,Kanjanavanit S,Rampon O,Faye A,Saïdi Y,Riault Y,De Rossi A,Klein N,Ananworanich J,Gibb D,PENTA 11 Extension Study GroupAIDS2013 Feb 20
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.Harrison L,Ananworanich J,Hamadache D,Compagnucci A,Penazzato M,Bunupuradah T,Mazza A,Ramos JT,Flynn J,Rampon O,Mellado Pena MJ,Floret D,Marczynska M,Puga A,Forcat S,Riault Y,Lallemant M,Castro H,Gibb DM,Giaquinto C,Paediatric European Network for Treatment of AIDS (PENTA) 11 Trial TeamAIDS Behav2013 Jan
Antiretroviral resistance among HIV type 1-infected women first exposed to antiretrovirals during pregnancy: plasma versus PBMCs.Soto-Ramirez LE,Rodriguez-Diaz R,Durán AS,Losso MH,Salomón H,Gómez-Carrillo M,Pampuro S,Harris DR,Duarte G,De Souza RS,Read JS,NISDI Perinatal Study GroupAIDS Res Hum Retroviruses2008 Jun
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.Cressey TR,Green H,Khoo S,Treluyer JM,Compagnucci A,Saidi Y,Lallemant M,Gibb DM,Burger DM,Paediatric European Network for Treatment of AIDS II Study GroupClin Infect Dis2008 May 15
Diminished human immunodeficiency virus type 1 DNA yield from dried blood spots after storage in a humid incubator at 37 degrees C compared to -20 degrees C.Mitchell C,Jennings C,Brambilla D,Aldrovandi G,Amedee AM,Beck I,Bremer JW,Coombs R,Decker D,Fiscus S,Fitzgibbon J,Luzuriaga K,Moye J,Palumbo P,Reichelderfer P,Somasundaran M,Stevens W,Frenkel L,Dried Blood Spot Working Group of the Infant Maternal Pediatric Adolescent AIDS Clinical Trials NetworkJ Clin Microbiol2008 Sep
Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.Pahwa S,Muresan P,Sleasman J,Fenton T,Moye J,Deveikis A,Wara D,Van Dyke R,Pediatric Aids Clinical Trials Study 402 teamJ Allergy Clin Immunol2007 Jun
Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children.Fletcher CV,DeVille JG,Samson PM,Moye JH Jr,Church JA,Spiegel HM,Palumbo P,Fenton T,Smith ME,Graham B,Kraimer JM,Shearer WT,Pediatric AIDS Clinical Trials Group, Protocol 351 Study GroupJ Allergy Clin Immunol2007 Mar
Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140).Shearer WT,DeVille JG,Samson PM,Moye JH Jr,Fletcher CV,Church JA,Spiegel HM,Palumbo P,Fenton T,Smith ME,Graham B,Kraimer JM,Olson WCJ Allergy Clin Immunol2006 Aug
Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection.Lambert JS,Harris DR,Stiehm ER,Moye J Jr,Fowler MG,Meyer WA 3rd,Bethel J,Mofenson LMJ Acquir Immune Defic Syndr2003 Dec 15
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.Krogstad P,Lee S,Johnson G,Stanley K,McNamara J,Moye J,Jackson JB,Aguayo R,Dieudonne A,Khoury M,Mendez H,Nachman S,Wiznia A,Pediatric AIDS Clinical Trials Group 377 Study TeamClin Infect Dis2002 Apr 1
Syphilis in HIV-infected Mothers and Infants: Results from the NICHD/HPTN 040 Study.Yeganeh N,Watts HD,Camarca M,Soares G,Joao E,Pilotto JH,Gray G,Theron G,Santos B,Fonseca R,Kreitchmann R,Pinto J,Mussi-Pinhata M,Ceriotto M,Maria Machado D,Veloso VG,Grinzstejn B,Morgado MG,Bryson Y,Mofenson LM,Nielsen-Saines K,NICHD HPTN 040P1043 Study TeamPediatr Infect Dis J2015 Mar
Laboratory abnormalities among HIV-1-infected pregnant women receiving antiretrovirals in Latin America and the Caribbean.Ceriotto M,Harris DR,Duarte G,Gonin R,Aguiar RP,Warley EM,Madi JM,Zala CA,Read JS,NICHD International Site Development Initiative (NISDI) Perinatal Study GroupAIDS Patient Care STDS2008 Mar
Current issues in the immunoprophylaxis of vertical transmission of HIV.Lambert JS,Moye JJBioDrugs1999 Jan
Quantification of human immunodeficiency virus type 1 p24 antigen and antibody rivals human immunodeficiency virus type 1 RNA and CD4+ enumeration for prognosis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Read JS,Rich KC,Korelitz JJ,Mofenson LM,Harris R,Moye JH Jr,Meyer WA 3rd,Pahwa SG,Bethel JW,Nugent RPPediatr Infect Dis J2000 Jun
Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children. National Institutes of Health-sponsored Pediatric AIDS Clinical Trials Group (ACTG-218).Lambert JS,McNamara J,Katz SL,Fenton T,Kang M,VanCott TC,Livingston R,Hawkins E,Moye J Jr,Borkowsky W,Johnson D,Yogev R,Duliege AM,Francis D,Gershon A,Wara D,Martin N,Levin M,McSherry G,Smith GJ Acquir Immune Defic Syndr Hum Retrovirol1998 Dec 15
Characteristics of acute pneumonia in human immunodeficiency virus-infected children and association with long term mortality risk. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Mofenson LM,Yogev R,Korelitz J,Bethel J,Krasinski K,Moye J Jr,Nugent R,Rigau-Perez JGPediatr Infect Dis J1998 Oct
The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Mofenson LM,Korelitz J,Meyer WA 3rd,Bethel J,Rich K,Pahwa S,Moye J Jr,Nugent R,Read JJ Infect Dis1997 May
Urinary concentrations of environmental phenols in pregnant women in a pilot study of the National Children's Study.Mortensen ME,Calafat AM,Ye X,Wong LY,Wright DJ,Pirkle JL,Merrill LS,Moye JEnviron Res2014 Feb
Iodine status in pregnant women in the National Children's Study and in U.S. women (15-44 years), National Health and Nutrition Examination Survey 2005-2010.Caldwell KL,Pan Y,Mortensen ME,Makhmudov A,Merrill L,Moye JThyroid2013 Aug
Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225.Chandwani S,Beeler J,Li H,Audet S,Smith B,Moye J,Nalin D,Krasinski K,PACTG 225 Study TeamJ Infect Dis2011 Jul
Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV.Crain MJ,Chernoff MC,Oleske JM,Brogly SB,Malee KM,Borum PR,Meyer WA 3rd,Mitchell WG,Moye JH,Ford-Chatterton HM,Van Dyke RB,Seage Iii GRJ Infect Dis2010 Jul 15
Steady-state pharmacokinetics of lopinavir/ritonavir in combination with efavirenz in human immunodeficiency virus-infected pediatric patients.King JR,Acosta EP,Yogev R,Wiznia A,Kraimer J,Graham B,Carey V,Britto P,Jean-Philippe P,Moye J,Watson DPediatr Infect Dis J2009 Feb
Selected persistent organic pollutants in human placental tissue from the United States.Nanes JA,Xia Y,Dassanayake RM,Jones RM,Li A,Stodgell CJ,Walker CK,Szabo S,Leuthner S,Durkin MS,Moye J,Miller RK,National Children’s Study Placenta ConsortiumChemosphere2014 Jul
Planned variation in preanalytical conditions to evaluate biospecimen stability in the National Children's Study (NCS).Mechanic L,Mendez A,Merrill L,Rogers J,Layton M,Todd D,Varanasi A,O'Brien B,Meyer Iii WA,Zhang M,Schleicher RL,Moye JClin Chem Lab Med2013 Dec
Three postpartum antiretroviral regimens to prevent intrapartum HIV infection.Nielsen-Saines K,Watts DH,Veloso VG,Bryson YJ,Joao EC,Pilotto JH,Gray G,Theron G,Santos B,Fonseca R,Kreitchmann R,Pinto J,Mussi-Pinhata MM,Ceriotto M,Machado D,Bethel J,Morgado MG,Dickover R,Camarca M,Mirochnick M,Siberry G,Grinsztejn B,Moreira RI,Bastos FI,Xu J,Moye J,Mofenson LM,NICHD HPTN 040/PACTG 1043 Protocol TeamN Engl J Med2012 Jun 21
Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life.Mirochnick M,Nielsen-Saines K,Pilotto JH,Pinto J,Veloso VG,Rossi S,Moye J,Bryson Y,Mofenson L,Camarca M,Watts DH,NICHD HPTN 040/PACTG 1043 PROTOCOL TeamPediatr Infect Dis J2011 Sep
The use of human tissues in research: what do we owe the research subjects?Gronowski AM,Moye J Jr,Wendler DS,Caplan AL,Christman MClin Chem2011 Apr
Associations of proinflammatory cytokine levels with lipid profiles, growth, and body composition in HIV-infected children initiating or changing antiretroviral therapy.Cervia JS,Chantry CJ,Hughes MD,Alvero C,Meyer WA 3rd,Hodge J,Borum P,Moye J Jr,Spector SA,PACTG 1010 TeamPediatr Infect Dis J2010 Dec
Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.Jacobson DL,Lindsey JC,Gordon CM,Moye J,Hardin DS,Mulligan K,Aldrovandi GM,Pediatric AIDS Clinical Trials Group P1045 teamAIDS2010 Mar 13
Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.Aldrovandi GM,Chu C,Shearer WT,Li D,Walter J,Thompson B,McIntosh K,Foca M,Meyer WA 3rd,Ha BF,Rich KC,Moye J JrPediatrics2009 Dec
Randomized controlled trial of feeding a concentrated formula to infants born to women infected by human immunodeficiency virus.Winter HS,Oleske JM,Hughes MD,McKinney RE Jr,Elgie C,Powell C,Purdue L,Puga AM,Jimenez E,Scott GB,Cruz ML,Moye J Jr,Pediatric AIDS Clinical Trials Group Protocol 247 Study TeamJ Pediatr Gastroenterol Nutr2009 Aug
Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.Aldrovandi GM,Lindsey JC,Jacobson DL,Zadzilka A,Sheeran E,Moye J,Borum P,Meyer WA 3rd,Hardin DS,Mulligan K,Pediatric AIDS Clinical Trials Group P1045 teamAIDS2009 Mar 27
Insulin-like growth factor-1 and lean body mass in HIV-infected children.Chantry CJ,Hughes MD,Alvero C,Cervia JS,Hodge J,Borum P,Moye J Jr,PACTG 1010 TeamJ Acquir Immune Defic Syndr2008 Aug 1
Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.Chantry CJ,Hughes MD,Alvero C,Cervia JS,Meyer WA 3rd,Hodge J,Borum P,Moye J Jr,PACTG 1010 TeamPediatrics2008 Jul
Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites in Latin American and Caribbean countries.Hazra R,Stoszek SK,Freimanis Hance L,Pinto J,Marques H,Peixoto M,Alarcon J,Mussi-Pinhata M,Serchuck L,NISDI Pediatric Study Group 2008Int J Epidemiol2009 Oct
Interventions to prevent vertical transmission of HIV-1: effect on viral detection rate in early infant samples.Dunn DT,Simonds RJ,Bulterys M,Kalish LA,Moye J Jr,de Maria A,Kind C,Rudin C,Denamur E,Krivine A,Loveday C,Newell MLAIDS2000 Jul 7
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.Mofenson LM,Lambert JS,Stiehm ER,Bethel J,Meyer WA 3rd,Whitehouse J,Moye J Jr,Reichelderfer P,Harris DR,Fowler MG,Mathieson BJ,Nemo GJN Engl J Med1999 Aug 5
Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Mofenson LM,Harris DR,Rich K,Meyer WA 3rd,Read JS,Moye J Jr,Nugent RP,Korelitz J,Bethel J,Pahwa SAIDS1999 Jan 14
Serum vitamin A concentrations in a North American cohort of human immunodeficiency virus type 1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Read JS,Bethel J,Harris DR,Meyer WA 3rd,Korelitz J,Mofenson LM,Moye J Jr,Pahwa S,Rich K,Nugent RPPediatr Infect Dis J1999 Feb
Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.Stiehm ER,Lambert JS,Mofenson LM,Bethel J,Whitehouse J,Nugent R,Moye J Jr,Glenn Fowler M,Mathieson BJ,Reichelderfer P,Nemo GJ,Korelitz J,Meyer WA 3rd,Sapan CV,Jimenez E,Gandia J,Scott G,O'Sullivan MJ,Kovacs A,Stek A,Shearer WT,Hammill HJ Infect Dis1999 Mar
Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group.Lambert JS,Mofenson LM,Fletcher CV,Moye J Jr,Stiehm ER,Meyer WA 3rd,Nemo GJ,Mathieson BJ,Hirsch G,Sapan CV,Cummins LM,Jimenez E,O'Neill E,Kovacs A,Stek AJ Infect Dis1997 Feb
Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group.Moye J Jr,Rich KC,Kalish LA,Sheon AR,Diaz C,Cooper ER,Pitt J,Handelsman EJ Pediatr1996 Jan
Sinusitis in children infected with human immunodeficiency virus: clinical characteristics, risk factors, and prophylaxis. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Mofenson LM,Korelitz J,Pelton S,Moye J Jr,Nugent R,Bethel JClin Infect Dis1995 Nov
Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Mofenson LM,Moye J Jr,Korelitz J,Bethel J,Hirschhorn R,Nugent RPediatr Infect Dis J1994 Jun
Effect of intravenous immunoglobulin (IVIG) on CD4+ lymphocyte decline in HIV-infected children in a clinical trial of IVIG infection prophylaxis. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Mofenson LM,Bethel J,Moye J Jr,Flyer P,Nugent RJ Acquir Immune Defic Syndr1993 Oct
Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.Mofenson LM,Moye J JrPediatr Res1993 Jan
The immunological and virological consequences of planned treatment interruptions in children with HIV infection.Klein N,Sefe D,Mosconi I,Zanchetta M,Castro H,Jacobsen M,Jones H,Bernardi S,Pillay D,Giaquinto C,Walker AS,Gibb DM,De Rossi A,Paediatric European Network for Treatment of AIDS 11 Trial TeamPLoS One2013
Perinatally acquired human immunodeficiency virus infection: extent of clinical recognition in a population-based cohort. Massachusetts Pediatric HIV Surveillance Working Group.Hsu HW,Moye J Jr,Kunches L,Ng P,Shea B,Caldwell B,Demaria A,Mofenson L,Grady GFPediatr Infect Dis J1992 Nov
Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.Mofenson LM,Moye J Jr,Bethel J,Hirschhorn R,Jordan C,Nugent RJAMA1992 Jul 22-29
Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children.Buchacz K,Cervia JS,Lindsey JC,Hughes MD,Seage GR 3rd,Dankner WM,Oleske JM,Moye JPediatrics2001 Oct
Recombinant CD4-IgG2 in human immunodeficiency virus type 1-infected children: phase 1/2 study. The Pediatric AIDS Clinical Trials Group Protocol 351 Study Team.Shearer WT,Israel RJ,Starr S,Fletcher CV,Wara D,Rathore M,Church J,DeVille J,Fenton T,Graham B,Samson P,Staprans S,McNamara J,Moye J,Maddon PJ,Olson WCJ Infect Dis2000 Dec
Treatment-mediated changes in human immunodeficiency virus (HIV) type 1 RNA and CD4 cell counts as predictors of weight growth failure, cognitive decline, and survival in HIV-infected children.Lindsey JC,Hughes MD,McKinney RE,Cowles MK,Englund JA,Baker CJ,Burchett SK,Kline MW,Kovacs A,Moye JJ Infect Dis2000 Nov
Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group.Smith R,Malee K,Charurat M,Magder L,Mellins C,Macmillan C,Hittleman J,Lasky T,Llorente A,Moye JPediatr Infect Dis J2000 Sep
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.Wiznia A,Stanley K,Krogstad P,Johnson G,Lee S,McNamara J,Moye J,Jackson JB,Mendez H,Aguayo R,Dieudonne A,Kovacs A,Bamji M,Abrams E,Rana S,Sever J,Nachman SAIDS Res Hum Retroviruses2000 Aug 10
Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment.Williams PL,Abzug MJ,Jacobson DL,Wang J,Van Dyke RB,Hazra R,Patel K,Dimeglio LA,McFarland EJ,Silio M,Borkowsky W,Seage GR 3rd,Oleske JM,Geffner ME,International Maternal Pediatric and Adolescent AIDS Clinical Trials P219219C Study and the Pediatric HIVAIDS Cohort StudyAIDS2013 Jul 31
Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group.Chase C,Ware J,Hittelman J,Blasini I,Smith R,Llorente A,Anisfeld E,Diaz C,Fowler MG,Moye J,Kaligh LIPediatrics2000 Aug
HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.Welles SL,Pitt J,Colgrove R,McIntosh K,Chung PH,Colson A,Lockman S,Fowler MG,Hanson C,Landesman S,Moye J,Rich KC,Zorrilla C,Japour AJAIDS2000 Feb 18
Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group.Garcia PM,Kalish LA,Pitt J,Minkoff H,Quinn TC,Burchett SK,Kornegay J,Jackson B,Moye J,Hanson C,Zorrilla C,Lew JFN Engl J Med1999 Aug 5
A comparison of peripheral blood coculture versus 18- or 24-month serology in the diagnosis of human immunodeficiency virus infection in the offspring of infected mothers. Women and Infants Transmission Study.McIntosh K,FitzGerald G,Pitt J,Bremer JW,Hillyer GV,Landesman S,Rosenblatt H,Lew JF,Davenny K,Moye JJ Infect Dis1998 Aug
Diagnosis of infection with human immunodeficiency virus type 1 by a DNA polymerase chain reaction assay among infants enrolled in the Women and Infants' Transmission Study.Bremer JW,Lew JF,Cooper E,Hillyer GV,Pitt J,Handelsman E,Brambilla D,Moye J,Hoff RJ Pediatr1996 Aug
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group.Comeau AM,Pitt J,Hillyer GV,Landesman S,Bremer J,Chang BH,Lew J,Moye J,Grady GF,McIntosh KJ Pediatr1996 Jul
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics.Lew J,Reichelderfer P,Fowler M,Bremer J,Carrol R,Cassol S,Chernoff D,Coombs R,Cronin M,Dickover R,Fiscus S,Herman S,Jackson B,Kornegay J,Kovacs A,McIntosh K,Meyer W,Michael N,Mofenson L,Moye J,Quinn T,Robb M,Vahey M,Weiser B,Yeghiazarian TJ Clin Microbiol1998 Jun
Immune complex-dissociated p24 antigen in congenital or perinatal HIV infection: role in the diagnosis and assessment of risk of infection in infants.Rich KC,Janda W,Kalish LA,Lew J,Hofheinz D,Landesman S,Pitt J,Diaz C,Moye J,Sullivan JLJ Acquir Immune Defic Syndr Hum Retrovirol1997 Jul 1
Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection.Rich KC,Brambilla D,Pitt J,Moye J,Cooper E,Hillyer G,Mendez H,Fowler MG,Landay AClin Immunol Immunopathol1997 Dec
Defining the time of fetal or perinatal acquisition of human immunodeficiency virus type 1 infection on the basis of age at first positive culture. Women and Infants Transmission Study (WITS).Kalish LA,Pitt J,Lew J,Landesman S,Diaz C,Hershow R,Hollinger FB,Pagano M,Smeriglio V,Moye JJ Infect Dis1997 Mar
After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group.Cooper ER,Nugent RP,Diaz C,Pitt J,Hanson C,Kalish LA,Mendez H,Zorrilla C,Hershow R,Moye J,Smeriglio V,Fowler MGJ Infect Dis1996 Dec
Prenatal mercury concentration is associated with changes in DNA methylation at TCEANC2 in newborns.Bakulski KM,Lee H,Feinberg JI,Wells EM,Brown S,Herbstman JB,Witter FR,Halden RU,Caldwell K,Mortensen ME,Jaffe AE,Moye J Jr,Caulfield LE,Pan Y,Goldman LR,Feinberg AP,Fallin MDInt J Epidemiol2015 Apr 22
Tuberculosis in human immunodeficiency virus-exposed or -infected United States children.Gutman LT,Moye J,Zimmer B,Tian CPediatr Infect Dis J1994 Nov
Blood culture in the first 6 months of life for the diagnosis of vertically transmitted human immunodeficiency virus infection. The Women and Infants Transmission Study Group.McIntosh K,Pitt J,Brambilla D,Carroll S,Diaz C,Handelsman E,Moye J,Rich KJ Infect Dis1994 Oct
Misdiagnosed HIV infection in pregnant women: implications for clinical care.Sheon AR,Fox HE,Alexander G,Buck A,Higgins A,McDermott SM,Moroso G,Moye J,Pacheco-Acosta EPublic Health Rep1994 Sep-Oct
Manipulating the immune system with immune globulin. The National Institute of Child Health and Human Development. Intravenous Immunoglobulin Study Group.Mofenson LM,Shearer WT,Moye J,Nugent R,Willoughby AN Engl J Med1992 Jun 11
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology